Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10073-10089

  Gorry, P R ^a   Bristol, G ^a   Zack, J A ^a   Ritola, K ^a   Swanstrom, R ^a   Birch, C J ^a   Bell, J E ^a   Bannert, N ^a   Crawford, K ^a   Wang, H ^a   Schols, D ^a   De Clercq, E ^a   Kunstman, K ^a   Wolinsky, S M ^a   Gabuzda, D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LYMPHOID TISSUE; MACROPHAGE; MICROGLIA; MONONUCLEAR CELL; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTIGENS, CD4; BRAIN; GENE PRODUCTS, ENV; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOID TISSUE; MACROPHAGES; MICROGLIA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV; VIRUS REPLICATION;

EID: 0034796289     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.21.10073-10089.2001     Document Type: Article

References (110)

1. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates
2. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
3. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
4. A small molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
5. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary HIV-1 isolate
6. The level of CD4 expression limits infection of primary, rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses
7. Human immunodeficiency virus and the brain: Investigation of virus load and neuropathologic changes in pre-AIDS subjects
8. Structural variations of O-linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T-lymphoid cells
9. Unique HIV type 1 V3 region sequences derived from six different regions of brain: Region-specific evolution within host-determined quasispecies
10. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
11. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1
12. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
13. 3C chemokine fractalkine and a fusion coreceptor for HIV-1
14. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
15. The level of HIV infection of macrophages is determined by interaction of viral and host cell genotypes
16. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: A further obstacle to eradication
17. Identification of a major co-receptor for primary isolates of HIV-1
18. Expression cloning of new receptors used by simian and human immunodeficiency viruses
19. A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
20. HIV type 1 V3 sequences and the development of dementia during AIDS
21. HIV-1 tropism and co-receptor use
22. Biological characterization of human immunodeficiency virus type I clones derived from different organs of an AIDS patient by long-range PCR
23. Beyond receptor expression: The influence of receptor conformation, density, and affinity in HIV-1 infection
24. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop
25. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
26. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors
27. + cells is mediated by the chemokine receptor CC-CKR-5
28. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type I and simian immunodeficiency virus envelope proteins
29. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type I and simian immunodeficiency virus
30. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo
31. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
32. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
33. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
34. HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle
35. Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells
36. Chemokine receptors and virus entry in the central nervous system
37. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS
38. The role of mononuclear phagocytes in HTLV-III LAV infection
39. Gp120 sequence variation in brain and in T-lymphocyte human immunodeficiency virus type 1 isolates
40. Macrophage tropism of HIV-1
41. Human immunodeficiency virus neurotropism: An analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia
42. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
43. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes
44. Human immunodeficiency virus (HIV) distribution in HIV encephalitis: Study of 19 cases with combined use of in situ hybridization and immunocytochemistry
45. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
46. Coreceptor ligand inhibition of fetal brain cell infection by HIV Type 1
47. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins
48. Infection of monocyte/macrophages by human T lymphotropic virus type III
49. Species-specific, postentry barriers to primate immunodeficiency virus infection
50. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains
51. gag and env genes
52. Relationship between productive HIV-1 infection of macrophages and CCR5 utilization
53. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection
54. mac chimeric virus whose env gene was derived from SIV-encephalitic brain is macrophage tropic but not neurovirulent
55. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism
56. Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: Evidence for distinct levels of restriction in primary macrophages and a T-cell line
57. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops
58. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences
59. Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission
60. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5
61. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages
62. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates
63. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: Evidence for limited defectiveness and complementation
64. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
65. Dementia associated with the acquired immunodeficiency syndrome
66. KU-2 that causes AiDS, neurological disease, and renal disease in rhesus macaques
67. Pathogenesis of simian immunodeficiency virus encephalitis: Viral determinants of neurovirulence
68. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro
69. Syncytium-inducing phenotype and zidovudine susceptibility of HIV-1 isolated from post-mortem tissue
70. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease
71. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein
72. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages
73. Mechanisms for adaptation of simian immunodeficiency virus to replicate in alveolar macrophages
74. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages using twins
75. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
76. Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection
77. Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay
78. Isolation of human immunodeficiency virus (HIV) at autopsy one to six days postmortem
79. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside of the CD4-binding domain
80. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleoside precursors
81. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope
82. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene
83. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
84. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodefieiency virus type 1
85. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences
86. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients
87. Neurological complications of HIV infection
88. Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis
89. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
90. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains
91. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
92. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
93. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
94. Independent evolution of HIV type 1 in different brain regions
95. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia
96. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells
97. Latency and reservoirs for HIV-1
98. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
99. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic, and most can use either LESTR or CCR5 as coreceptors
100. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodefieiency virus type 1 primary-isolate quasispecies
101. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): Evidence for neurotropic HIV variants
102. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy
103. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: Evidence of differential tropism
104. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy
105. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates
106. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
107. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
108. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
109. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia
110. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia